ADVERTISEMENT

Select Columnist:
Hagop M. Kantarjian, MD

Hagop M. Kantarjian, MD

Hagop M. Kantarjian, MD, is Professor and Chairman, Department of Leukemia, and Associate Vice President for Global Academic Programs, The University of Texas MD Anderson Cancer Center, Houston.
Latest Articles

  • Chemotherapy Drug Shortages: A Preventable Human Disaster - Monday, November 14, 2011

Read Bio

Read Bio

  • Breast cancer (152)
  • Direct from ASCO (55)
  • Lung cancer (67)
  • Lymphoma (49)
  • Prostate cancer (44)
  • Leukemia (30)
  • Other (31)
  • Colorectal cancer (23)
  • Gastrointestinal cancer (27)
  • Appointments (18)
  • Melanoma (20)
  • Multiple myeloma (18)
  • Perspective (19)
  • Genitourinary cancer (25)
  • Colon cancer (14)
  • more...

ADVERTISEMENT

ADVERTISEMENT



#FDA’s $6.4 Billion Plan For Quick Reviews Moves To Senate (via Bloomberg) http://t.co/NGMtNfBk
about 13 hours ago via web

#LungCancer CT Scans: Just for Older Heavy #Smokers (via AP) http://t.co/7j0lqhGm
about 15 hours ago via web

#Immunotherapy Clinical Trials Show Benefits for Patients with Advanced #Cancer http://t.co/jma6OOYG
about 15 hours ago via web

Dr. James A. Stewart on Maintenance of Certification in Medical #Oncology http://t.co/6xcTrMqj
about 15 hours ago via web

.@SalpyTalatinian Thanks for the retweet!
about 3 days ago via web

© 2012 HSP News Service, L.L.C.
Advertising  |  Disclosures  |  Contact TAP  |  Privacy Policy  |  Disclaimer